Agenus (AGEN) Gross Profit Growth (1y) (2011 - 2026)

Agenus (AGEN) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 41.37%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.76%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 16.94%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 68.41%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Agenus 234.10 Mn 199.10 Mn 33.74 Mn 40.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 40.98%
Dec 31, 2025 968.77%
Sep 30, 2025 18.53%
Jun 30, 2025 8.78%
Mar 31, 2025 -14.23%
Dec 31, 2024 -102.53%
Sep 30, 2024 3.98%
Jun 30, 2024 -6.58%
Mar 31, 2024 35.37%
Dec 31, 2023 194.08%
Sep 30, 2023 6.89%
Jun 30, 2023 32.48%
Mar 31, 2023 -18.86%
Dec 31, 2022 -368.48%
Sep 30, 2022 -91.09%
Jun 30, 2022 87.84%
Mar 31, 2022 139.29%
Dec 31, 2021 -36.38%
Sep 30, 2021 1,711.20%
Jun 30, 2021 -61.75%